macrolides are active against streptococcus pneumoniae , legionella spp . and mycoplasma pneumoniae , the main causes of community-acquired pneumonia they may therefore be used for the empirical treatment of community-acquired pneumonia , although emergent resistance in str . pneumoniae limits their use in some parts of the world .
C0694549
community-acquired pneumonia
C0032285
pneumoniae